Epidemiology of neurocognitive disorders in france

Rochoy, Michael; Chazard, Emmanuel; Bordet, Regis

Document type :

Article dans une revue scientifique: Article original

DOI :

10.1684/pnv.2018.0778

PMID :

30907374

Permalink :

http://hdl.handle.net/20.500.12210/15889

Title :

Epidemiology of neurocognitive disorders in france

Author(s) :

Rochoy, Michael [Auteur]
Chazard, Emmanuel [Auteur]

Bordet, Regis [Auteur]

Troubles cognitifs dégénératifs et vasculaires - U 1171 - EA 1046 [TCDV]
Troubles cognitifs dégénératifs et vasculaires - U 1171 - EA 1046 [TCDV]
Troubles cognitifs dégénératifs et vasculaires - U1171

Journal title :

Geriatrie et psychologie neuropsychiatrie du vieillissement

Abbreviated title :

Geriatr Psychol Neuropsychiatr Vieil

Volume number :

Pages :

99-105

Publication date :

2019-03-01

ISSN :

2115-7863

English keyword(s) :

France
cohort studies
incidence
epidemiology
dementia
prevalence

HAL domain(s) :

Sciences du Vivant [q-bio]

English abstract : [en]

Neurocognitive disorders are common: every year, any physician or health professional comes into contact with patients or relatives with early symptoms of dementia. Nevertheless, their epidemiology remains difficult to ...
Show more >Neurocognitive disorders are common: every year, any physician or health professional comes into contact with patients or relatives with early symptoms of dementia. Nevertheless, their epidemiology remains difficult to estimate, due to real differences in risk factors within a country or region (average age, genetics, level of education, socio-economic level, etc.), differences in data collection, in the interpretation of these data with regard to scientific findings and changes in diagnostic criteria. In this review, we present a state of knowledge of the epidemiology of dementia in France. Epidemiological data on neurocognitive disorders in France come mainly from 3 sources: two prospective cohorts (PAQUID and 3C) and large databases (SNIIRAM, RSI data, PMSI). Neurocognitive disorders are estimated to directly affect more than 1.2 million people in France and about 2 out of 3 cases are attributed to Alzheimer's disease. The prevalence rate is estimated at about 40/1,000 people after 60 years of age and gradually increases to 180/1,000 after 75 years of age, reaching almost one in two people after 90 years of age. The incidence rate is estimated at between 13 and 19/1,000 person-years, and seems to decrease slightly over the decades. The PAQUID and 3C cohorts are coming to an end; despite the development of large databases (SNIIRAM, PMSI, etc.), it seems necessary to continue to set up new prospective cohorts in the general population to monitor the epidemiology of neurocognitive disorders in France.Show less >

Language :

Anglais

Audience :

Internationale

Popular science :

Non

Administrative institution(s) :

CHU Lille
CNRS
Inserm
Université de Lille

Collections :

Lille Neurosciences & Cognition (LilNCog) - U 1172

Research team(s) :

Troubles cognitifs dégénératifs et vasculaires

Submission date :

2019-11-27T13:02:04Z

Epidemiology of neurocognitive disorders in france BibTeX CSV Excel RIS

Epidemiology of neurocognitive disorders in france

BibTeX

CSV

Excel

RIS